# Aspirin Attenuates Inflammation in Human Cerebral Aneurysms

> **NCT01710072** · PHASE1 · COMPLETED · sponsor: **University of Iowa** · enrollment: 11 (actual)

## Conditions studied

- The Focus of the Study is to Monitor MRI Signal Changes and Inflammatory Biomarkers With Use of Aspirin in Patients With Unruptured Cerebral Aneurysm

## Interventions

- **DRUG:** aspirin

## Key facts

- **NCT ID:** NCT01710072
- **Lead sponsor:** University of Iowa
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2015-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01710072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01710072, "Aspirin Attenuates Inflammation in Human Cerebral Aneurysms". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01710072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*